| P50 | author | Hisao Ogawa | Q114427064 |
| P2093 | author name string | Satoshi Araki | |
| | Shinsuke Hanatani | |
| | Taku Rokutanda | |
| | Yasuhiro Izumiya | |
| | Hiroki Usuku | |
| P2860 | cites work | Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy | Q28297738 |
| | Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. | Q28569799 |
| | Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts | Q28575103 |
| | Adiponectin-mediated modulation of hypertrophic signals in the heart | Q33688678 |
| | Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases | Q33852885 |
| | AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle | Q34406367 |
| | Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. | Q35315318 |
| | The role of natriuretic peptides in cardioprotection | Q36313449 |
| | Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions | Q36314468 |
| | Role of oxidative stress in cardiac hypertrophy and remodeling | Q36693221 |
| | Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. | Q36954799 |
| | CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis. | Q51055827 |
| | Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. | Q51813812 |
| | Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. | Q52926690 |
| | Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II | Q77198542 |
| | Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes | Q80062989 |
| | Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure | Q80517787 |
| | Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha | Q80794574 |
| | C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction | Q81397064 |
| | Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement | Q37678374 |
| | C-type natriuretic peptide and its receptors in atherosclerotic plaques of the carotid artery of clinically asymptomatic patients. | Q39640315 |
| | Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. | Q40284468 |
| | Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" | Q40512524 |
| | Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways | Q42456333 |
| | Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy | Q43869305 |
| | Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. | Q44028496 |
| | Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. | Q44301908 |
| | Myocardial production of C-type natriuretic peptide in chronic heart failure | Q44302077 |
| | Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy | Q44613107 |
| | Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox | Q44774808 |
| | Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. | Q46435005 |
| | Angiotensin II regulates cardiac hypertrophy via oxidative stress but not antioxidant enzyme activities in experimental renovascular hypertension | Q46687583 |
| | Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein | Q46830868 |
| | Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan | Q46833898 |
| | Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials | Q46928598 |
| | C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity | Q48880133 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | C-Type natriuretic peptide | Q78190979 |
| P304 | page(s) | 246058 | |
| P577 | publication date | 2012-07-17 | |
| P1433 | published in | International Journal of Vascular Medicine | Q26842151 |
| P1476 | title | Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling | |
| P478 | volume | 2012 | |